HIGHLIGHTS
- who: Posted Date August and collaborators from the Laboratory findings on admission, No(%) have published the article: Incidence of Bloodstream Infections in Patients with COVID-19: A Retrospective Cohort Study of Risk Factors and Outcomes, in the Journal: (JOURNAL)
- what: The authors did not have information on immunomodulatory therapies such as tocilizumab, which has been associated with increased risk of BSIs in critically ill patients with COVID-19.[29] the study has several strengths.
- how: For multivariable analysis the authors used logistic regression to identify independent predictors of BSIs during the hospital stay . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.